For the Inventor, By the Inventor

Enter inventor name

Potomac, MD, United States of America

Mario H Skiadopoulos

This inventor holds 14 USPTO granted patents and 4 published patent applications and 5 EPO patents. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, The United States of America. Active years: 2007-2015.

USPTO Granted Patents = 14 (Patent Applications = 4)

% Patents Active = 85.7

EPO Patents = 5 (Patent Applications = 2)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 111(Granted Patents)

Company Filing History:

12 out of 3,690

The United States of America, as Represented by the Secretary, Department of Health and Human Services

The United States of America

Years Active: 2007-2015

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9034343 - Attenuated human parainfluenza virus, methods and uses thereof (2015-05-19),

2. 8367074 - Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2013-02-05),

3. 7951383 - Attenuated parainfluenza virus (PIV) vaccines (2011-05-31),

4. 7919301 - Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from CDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2011-04-05),

5. 7820181 - Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2010-10-26),

6. 7704509 - Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of recombinant HPIV1 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens (2010-04-27),

7. 7704491 - Recombinant human metapneumovirus and its use (2010-04-27),

8. 7632508 - Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines (2009-12-15),

9. 7622123 - Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines (2009-11-24),

10. 7314631 - Use of recombinant live-attenuated parainfluenza virus (PIV) as a vector to protect against disease caused by PIV and respiratory syncytial virus (RSV) (2008-01-01),

11. 7250171 - Construction and use of recombinant parainfluenza viruses expressing a chimeric glycoprotein (2007-07-31),

12. 7208161 - Production of attenuated parainfluenza virus vaccines from cloned nucleotide sequences (2007-04-24),

13. 7201907 - Attenuated human-bovine chimeric parainfluenza virus(PIV) vaccines (2007-04-10),

14. 7192593 - Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens (2007-03-20),

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]

Loading…